Stifel Nicolaus Has Lowered Expectations for Cooper Companies (NASDAQ:COO) Stock Price

Cooper Companies (NASDAQ:COO) had its price target dropped by stock analysts at Stifel Nicolaus from $95.00 to $85.00 in a report released on Friday,Benzinga reports. The firm presently has a “buy” rating on the medical device company’s stock. Stifel Nicolaus’ price target would indicate a potential upside of 27.45% from the stock’s previous close.

A number of other research analysts have also issued reports on the stock. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research note on Wednesday, May 27th. Needham & Company LLC reduced their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a research report on Friday. Robert W. Baird lowered their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research report on Friday. Finally, Wells Fargo & Company reissued a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a research note on Friday. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $83.14.

Cooper Companies Stock Performance

Shares of NASDAQ COO traded up $4.67 during mid-day trading on Friday, hitting $66.69. 1,938,826 shares of the company were exchanged, compared to its average volume of 2,219,373. The stock has a 50 day simple moving average of $65.17 and a 200-day simple moving average of $74.57. Cooper Companies has a 1-year low of $58.89 and a 1-year high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The firm has a market cap of $13.01 billion, a price-to-earnings ratio of 33.01, a price-to-earnings-growth ratio of 1.56 and a beta of 0.87.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, sell-side analysts forecast that Cooper Companies will post 4.62 EPS for the current fiscal year.

Institutional Trading of Cooper Companies

A number of institutional investors have recently bought and sold shares of COO. New York Life Investment Management LLC lifted its stake in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after buying an additional 158 shares during the period. Root Financial Partners LLC increased its stake in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 162 shares during the period. Essential Partners LLC increased its stake in Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after acquiring an additional 166 shares during the period. Allworth Financial LP increased its stake in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after acquiring an additional 167 shares during the period. Finally, Mesirow Financial Investment Management Inc. increased its stake in Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after acquiring an additional 175 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.